These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1234594)

  • 21. Flucloxacillin in chronic leg ulcers. Penetration of flucloxacillin into chronic leg ulcer exudate and the effect on the bacteria.
    Stürup J; Sandberg Sørensen T; Slotsbjerg T; Hofmann B
    Acta Pathol Microbiol Immunol Scand B; 1987 Aug; 95(4):213-7. PubMed ID: 3673578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flucloxacillin treatment of methicillin-'resistant' and sensitive staphylococcal infection.
    Kidson A; Lilly HA; Lowbury EJ
    J Antimicrob Chemother; 1979 Jul; 5(4):359-64. PubMed ID: 489489
    [No Abstract]   [Full Text] [Related]  

  • 23. Pacemaker infections. A clinical study with special reference to prophylactic use of some isoxazolyl penicillins.
    Bluhm G
    Acta Med Scand Suppl; 1985; 699():1-62. PubMed ID: 3904338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A general practice trial of an amoxycillin/flucloxacillin combination (Suprapen) in proven bacterial infections.
    Kritzinger NA
    J Int Med Res; 1979; 7(6):531-4. PubMed ID: 391627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bacteriological studies on synergism between amoxicillin and flucloxacillin (author's transl)].
    Ochiai H; Terao M; Miyamura S
    Jpn J Antibiot; 1976 Dec; 29(12):1042-7. PubMed ID: 1051433
    [No Abstract]   [Full Text] [Related]  

  • 26. Facial cellulitis responsive to flucloxacillin in acute leukemia.
    Barrett AP
    Ann Dent; 1989; 48(1):28-9. PubMed ID: 2675747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antistaphylococcal activity of propicillin, oxacillin and dichloxacillin compared with that of penicillin G].
    Bevilacqua RL; Ciaffi G; Ravagnan L
    Antibiotica; 1967 Dec; 5(4):282-92. PubMed ID: 4981826
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy and prevention of infectious endocarditis].
    Horstkotte D; Rosin H
    Schweiz Med Wochenschr; 1984 Nov; 114(45):1575-86. PubMed ID: 6515354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Flucloxacillin, a new staphylococcal antibiotic. In-vitro activity and pharmacokinetics].
    Simon C; Malerczyk V; Hodgson B
    Dtsch Med Wochenschr; 1973 Aug; 98(32):1502-6. PubMed ID: 4489895
    [No Abstract]   [Full Text] [Related]  

  • 30. [Endothelial damage caused by the semisynthetic penicillins cloxacillin dicloxacillin and flucloxacillin].
    Sinapius D; Bründel KH
    Vasa; 1975; 4(1):54-8. PubMed ID: 1189592
    [No Abstract]   [Full Text] [Related]  

  • 31. "Methicillin-resistant" Staphylococcus aureus: reassessment by controlled trial in burns unit.
    Lowbury EJ; Lilly HA; Kidson A
    Br Med J; 1977 Apr; 1(6068):1054-6. PubMed ID: 322817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study of the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections.
    Rodriguez-Solares A; Pérez-Gutiérrez F; Prosperi J; Milgram E; Martin A
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():103-9. PubMed ID: 8396081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [On flucloxacillin sensitivity determination by the disc method (author's transl)].
    Kanazawa Y; Kuramata T
    Jpn J Antibiot; 1975 Feb; 28(1):48-52. PubMed ID: 1092891
    [No Abstract]   [Full Text] [Related]  

  • 34. [Blood levels of amoxicillin in humans after oral administration, singly or in combinations].
    Benoni G; Minelli Bertazzoni E; Berti T
    Clin Ter; 1978 Aug; 86(4):311-8. PubMed ID: 367680
    [No Abstract]   [Full Text] [Related]  

  • 35. Bactericidal activity and pharmacology of flucloxacillin.
    Bergeron MG; Brusch JL; Barza M; Weinstein L
    Am J Med Sci; 1976; 271(1):13-20. PubMed ID: 3969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [General characteristics of polysynthetic penicillins].
    Doĭl FP
    Antibiotiki; 1971 Oct; 16(10):870-7. PubMed ID: 5003054
    [No Abstract]   [Full Text] [Related]  

  • 37. [In vitro and in vivo antibacterial activity of combined flucloxacillin-cefacetrile (Flunicef)].
    Venturini AP; Stanzani L; Mantovani V; Mascellani G
    G Ital Chemioter; 1979; 26(1-2):153-8. PubMed ID: 554805
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical evaluation of flucloxacillin in the treatment of serious staphylococcal infections in children].
    Saied H; Ben Attia M
    J Int Med Res; 1986; 14(5):261-6. PubMed ID: 3770291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative bioavailability and half-lives of cloxacillin and flucloxacillin.
    Paton DM
    Int J Clin Pharmacol Res; 1986; 6(5):347-9. PubMed ID: 3781696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of the combination of teicoplanin or flucloxacillin with netilmicin in the treatment of Staphylococcus aureus bacteraemia.
    Degener JE; Vogel M; Michel MF; Mutsaers MM; Hop WC
    J Antimicrob Chemother; 1989 Jun; 23(6):899-904. PubMed ID: 2527224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.